Addressing the Bundibugyo Ebola Outbreak: A New Continental Response Plan

The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) have launched a joint continental preparedness and response plan to address the ongoing Ebola outbreak caused by the Orthoebolavirus bundibugyoense, commonly known as the Bundibugyo virus. This initiative seeks to mobilize US$ 518 million to support affected nations and bolster regional health systems against the threat.

Understanding the Current Situation

As of May 16, 2026, health authorities reported 246 suspected cases and 80 deaths associated with the current outbreak, which originated in the Ituri Province of the Democratic Republic of the Congo (DRC). The National Institute of Biomedical Research (INRB) confirmed the involvement of the Bundibugyo virus in samples collected from the Mongbwalu and Rwampara health zones.

The virus, which causes Ebola disease, typically presents with symptoms including fever, generalized body pain, weakness, and vomiting, with some patients experiencing internal or external bleeding. The outbreak is complicated by regional factors, including population displacement, mining-related movement, and frequent cross-border travel, which elevate the risk of transmission. A case of Bundibugyo virus disease has also been confirmed in Uganda in a patient who traveled from the DRC.

The ‘One Response’ Strategy

The newly unveiled six-month plan, spanning June to November 2026, adopts a “One Response” approach. This strategy aims to unify governments, international partners, and local communities under a singular framework for action. Key pillars of the response include:

• Emergency Coordination: Streamlining efforts between the DRC, Uganda, and regional bodies.
• Disease Surveillance and Laboratory Testing: Rapidly identifying and confirming new cases to interrupt chains of transmission.
• Clinical Care and Infection Prevention: Enhancing the safety and efficacy of care provided to patients.
• Community Engagement: Placing local populations at the center of the response to build trust and improve the success of contact tracing.
• Logistics and Essential Services: Ensuring that the response to Ebola does not disrupt the management of other ongoing health challenges, such as mpox, cholera, and measles.

Challenges and Future Outlook

A significant hurdle in the current response is the lack of licensed vaccines or therapeutics specifically approved for the Bundibugyo species of the Ebola virus. The plan places a heavy emphasis on strengthening overall health system resilience and implementing robust screening at points of entry.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted that containing the virus depends on political commitment, sustained financing, and the active participation of communities. Similarly, Dr. Jean Kaseya, Director-General of Africa CDC, emphasized the need for speed and unity, noting that the continent must act collectively to protect lives and support affected communities.

Key Takeaways

• Virus Type: The outbreak is caused by the Bundibugyo virus, a species of Orthoebolavirus.
• Geographic Scope: Primarily centered in Ituri Province, DRC, with confirmed cases in Uganda.
• Funding Goal: The joint Africa CDC and WHO plan aims to raise US$ 518 million.
• Public Health Focus: The response prioritizes community engagement, cross-border coordination, and the maintenance of essential health services.

As response operations accelerate, the focus remains on curbing the spread of the virus through evidence-based public health measures. While the current risk of international spread to regions outside of the affected area remains low, the coordinated continental effort serves as a critical step in managing the immediate emergency while building the capacity to detect and respond to future health threats.